1-3 of 3
Frank Schwoebel, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Double Blind Placebo Controlled PK/PD Study On the Effects of a Single Intravenous Dose of the Anti-Hepcidin Spiegelmer Nox-H94 On Serum Iron During Experimental Human Endotoxemia

Lucas van Eijk, MD, Dorine W. Swinkels, MD, PhD, John Aaron, Frank Schwoebel, PhD, Frank Fliegert, MD, Luciana Summo, PharmD PhD, Vauleon Stéphanie, PhD, Coby Laarakkers, BSc, Kai Riecke, MD, Peter Pikkers, MD PhD
Journal: Blood
Blood (2012) 120 (21): 3452.
https://doi.org/10.1182/blood.V120.21.3452.3452
Published: 2012
Journal Articles

Single and Repeated Dose First-in-Human Study with the Anti-Hepcidin Spiegelmer Nox-H94.

Kai Riecke, MD, Stefan Zöllner, PhD, Malcolm Boyce, MD, Stephanie Vauléon, PhD, Dorine W. Swinkels, MD, PhD, Thomas Dümmler, PhD, Luciana Summo, PharmD PhD, Coby Laarakkers, BSc, Frank Schwoebel, PhD, Frank Fliegert, MD
Journal: Blood
Blood (2012) 120 (21): 2342.
https://doi.org/10.1182/blood.V120.21.2342.2342
Published: 2012
Journal Articles

Rapid and Efficient Mobilization of Murine Hematopoietic Stem and Progenitor Cells with Nox-A12, a New Spiegelmers®-Based CXCR4/SDF-1(CXCL12) Antagonist

Marina Scheller, PhD, Frank Schwoebel, PhD, Doerte Vossmeyer, PhD, Achim Leutz, PhD
Journal: Blood
Blood (2011) 118 (21): 2995.
https://doi.org/10.1182/blood.V118.21.2995.2995
Published: 2011